| CSL LTD SPON.ADR 2 |
| USA |
| Gesundheit |
| US12637N2045 / A115DF |
| CSJA (Frankfurt) |
| FRA:CSJA, ETR:CSJA, CSJA:GR |
| - |
| https://www.csl.com/ |
|
CSL Ltd. is a global biotechnology firm known for its development, manufacture, and marketing of innovative biotherapies and influenza-related products. It primarily operates in two segments: CSL Behring, which focuses on innovative medicines for pat..
>Volltext.. |
| 41261.26 Mio. EUR |
| 51479.44 Mio. EUR |
| 13257.73 Mio. EUR |
| 4314.2 Mio. EUR |
| 1210.25 Mio. EUR |
| 0.63 EUR |
| 9649.01 Mio. EUR |
| 991.93 Mio. EUR |
| 3129.32 Mio. EUR |
| 0.25 |
| 1.56% |
| -49.01% |
| 0.97 EUR |
| 2.76% |
| 2.76% |
| 11.03.26 - 0.27988997€ 10.09.25 - 0.69497997€ >weitere anzeigen... |
| - |
| CSL ADR, CSL |
| 05.04.26 |
|
||||
|